Skip to main content
. 2016 Apr 5;6:23716. doi: 10.1038/srep23716

Figure 6.

Figure 6

Preventative effects of pGSMT/MG1363 on hepatic (A–C) and renal (D–F) functions. The serum parameters are expressed as the means ± S.E.s. Control: rats without treatment; model: 5 mg/kg/d lead-treated rats; pGS/MG1363: lead-treated rats administered 1 × 1010 CFU/d; and pGSMT/MG1363-L, pGSMT/MG1363-M, and pGSMT/MG1363-H: lead-treated rats administered 1 × 108, 1 × 109, and 1 × 1010 CFU/d, respectively. n = 9. The asterisks, *, ** and ***, indicate significant differences at p < 0.05, p < 0.01 and p < 0.001, respectively.